title: Screening for neuropathic pain after spinal cord injury with the spinal cord injury pain instrument (SCIPI): a preliminary validation study.
abstract: METHODS
  Cross-sectional.
  
  
  OBJECTIVE
  To preliminarily evaluate the validity of an interview-based spinal cord injury (SCI) neuropathic pain screening instrument.
  
  
  METHODS
  Six university-based SCI centers in the United States.
  
  
  METHODS
  Clinician diagnoses of neuropathic pain (NP) and non-neuropathic pain subtypes were collected independently of descriptions of the pain characteristics provided by the persons with SCI by using the Spinal Cord Injury Pain Instrument (SCIPI); SCIPI information and physician diagnoses for 82 pain sites of which they were most confident were subsequently compared.
  
  
  RESULTS
  Four of the SCIPI items correlated significantly with the NP subtype as determined by the clinician. The best cutoff score for identifying NP was an endorsement of two or more of these four items. Using this cutoff, sensitivity of the SCIPI was 78%, specificity was 73% and overall diagnostic accuracy was 76%.
  
  
  CONCLUSIONS
  In this preliminary study, the SCIPI, which can be administered by a nonclinician, appears to have good sensitivity, specificity and diagnostic accuracy in a SCI population; it may have a role as a screening tool for NP after SCI. Further study is needed.
authors.affiliation: Department of Rehabilitation Medicine, Icahn School of Medicine at Mount Sinai, The Mount Sinai Medical Center, New York, NY, USA.
authors.forename: T N
authors.initials: TN
authors.lastname: Bryce
authors.affiliation: Department of Physical Medicine and Rehabilitation, University of Alabama at Birmingham, Birmingham, AL, USA.
authors.forename: J S
authors.initials: JS
authors.lastname: Richards
authors.affiliation: Department of Rehabilitation Medicine, University of Washington, Seattle, WA, USA.
authors.forename: C H
authors.initials: CH
authors.lastname: Bombardier
authors.affiliation: Department of Rehabilitation Medicine, Icahn School of Medicine at Mount Sinai, The Mount Sinai Medical Center, New York, NY, USA.
authors.forename: M P
authors.initials: MP
authors.lastname: Dijkers
authors.affiliation: Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA.
authors.forename: J R
authors.initials: JR
authors.lastname: Fann
authors.affiliation: Department of Rehabilitation Medicine, University of Miami Leonard M. Miller School of Medicine, Miami, FL, USA.
authors.forename: L
authors.initials: L
authors.lastname: Brooks
authors.affiliation: Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI, USA.
authors.forename: A
authors.initials: A
authors.lastname: Chiodo
authors.affiliation: Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI, USA.
authors.forename: D G
authors.initials: DG
authors.lastname: Tate
authors.affiliation: Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI, USA.
authors.forename: M
authors.initials: M
authors.lastname: Forchheimer
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use; D003430:Cross-Sectional Studies; D003511:Cyclohexanols / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009437:Neuralgia / Q000175:diagnosis* / Q000209:etiology*; D010147:Pain Measurement / Q000379:methods*; D025341:Principal Component Analysis; D011594:Psychometrics; D012372:ROC Curve; D015203:Reproducibility of Results; D057566:Self Report; D013119:Spinal Cord Injuries / Q000150:complications* / Q000523:psychology; D011795:Surveys and Questionnaires; D014481:United States; D000069470:Venlafaxine Hydrochloride; D055815:Young Adult
chemical_list: D000928:Antidepressive Agents; D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride